Qube Research & Technologies (QRT)’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.2M Buy
+287,543
New +$15.7M 0.01% 1269

Other funds holding ELVN

Qube Research & Technologies (QRT)'s ELVN Position: Q3 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Enliven Therapeutics (ELVN) in Q3 2026: 287,543 shares worth $13.2M. The stake represents 0.01% of the portfolio and ranks #1269 among its holdings.

216 funds tracked by Wall St. Rank hold ELVN as of Q3 2026.

  • Qube Research & Technologies (QRT) held 287,543 shares of Enliven Therapeutics worth $13.2M as of Q3 2026.
  • Enliven Therapeutics was a new Qube Research & Technologies (QRT) position in Q3 2026.
  • Enliven Therapeutics made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #1269 holding.
  • 216 funds tracked by Wall St. Rank held Enliven Therapeutics as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.